PTGX icon

Protagonist Therapeutics

66 hedge funds and large institutions have $226M invested in Protagonist Therapeutics in 2017 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 28 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$18.7M
2 +$11.2M
3 +$8.31M
4
BI
BVF Inc
California
+$6.12M
5
DM
Deerfield Management
New York
+$4.68M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$63.9M
2
$42.8M
3
$18.7M
4
$10.3M
5
$10M
6
$8.66M
7
$8.32M
8
$6.12M
9
$5.72M
10
$4.68M
11
$4.26M
12
$4.01M
13
$3.74M
14
$3.69M
15
$2.91M
16
$2.85M
17
$2.65M
18
$2.5M
19
$2.08M
20
$1.72M
21
$1.2M
22
$1.04M
23
$1.04M
24
$971K
25
$925K